Skin cancer risk in people living with HIV: a call for action

Lancet HIV. 2024 Jan;11(1):e60-e62. doi: 10.1016/S2352-3018(23)00202-3. Epub 2023 Oct 18.

Abstract

A diagnosis of HIV poses secondary medical risks to patients, ranging from infections to neoplastic conditions. Regarding skin cancer, these risks extend beyond the well known association with Kaposi sarcoma and include Merkel cell carcinoma, squamous cell carcinoma, and high-risk melanomas. Despite evidence of these risks, knowledge and awareness remain low, among care providers for people living with HIV, individual patients, and even some specialists in dermatology. Crucially, medical organisations do not adequately address this concern, as there is an absence of treatment guidelines for the screening and management of skin cancer for people living with HIV. To continue providing high-quality care for this population, the increased risk of multiple high-risk skin cancers needs to be appropriately recognised by both providers and patients. Accordingly, we call for renewed emphasis on patient education and implementation of improved organisational guidelines for skin cancer screening protocols.

Publication types

  • Review

MeSH terms

  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • Humans
  • Risk
  • Sarcoma, Kaposi* / epidemiology
  • Skin Neoplasms* / complications
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / epidemiology